Does Liposomal NAD+ Liquid Absorb Better Than Capsules?

Liposomal NAD+ Resveratrol — berry liquid bottle with a teaspoon serving
Get NutraHack Labs in your Google results:

TL;DR

  • "Liposomal" describes a delivery technique that wraps an ingredient in a phospholipid shell, a strategy studied for various nutrients to help them survive the digestive process — it is not the same question as liquid versus capsule.
  • No published human trial has directly compared liposomal NAD+ precursor liquid against standard capsules for absorption, so claims either way outrun the evidence.
  • What the research does show is that oral nicotinamide riboside (NR), in ordinary capsule form, reliably raises blood NAD+ metabolites in the specific trials that measured it.
  • Liposomal capsules (soft-gel style capsules containing a liposomal formulation) are a middle path: a delivery technique without the inconvenience of a liquid.
  • NutraHack Labs' Liposomal NAD+ Resveratrol is a liposomal liquid with 300 mg nicotinamide riboside, not NMN, and 100 mg trans-resveratrol per 4 mL serving.

The product in this guide: Liposomal NAD+ Resveratrol — buy now →

What "Liposomal" Actually Means

The word liposomal gets used a lot in supplement marketing, often without much explanation. A liposome is a small sphere made of phospholipids — the same kind of molecules that make up cell membranes — arranged so that they can encase another compound inside. The idea, studied across a range of nutrients over the years, is that this capsule-like shell may help a compound travel through the digestive tract with less breakdown before it reaches the bloodstream.

This is a delivery technique, not a form factor. A liposomal formulation can be put into a liquid, a soft-gel capsule, or even a powder. That distinction matters because a lot of marketing collapses "liposomal" and "liquid" into the same idea, when they are actually two separate variables: how an ingredient is packaged at the molecular level, and what shape the final consumer product takes.

Why This Confusion Persists

Liquid liposomal products are often marketed as inherently superior because the liposomal technique first became popular in liquid form. But a liposomal ingredient can just as easily be encapsulated into a standard capsule after manufacturing. The technique and the format are not the same decision, and conflating them makes it harder to evaluate either one on its own merits.

What the Research Actually Shows About NAD+ Precursors

Before getting into delivery format, it helps to look at what has actually been measured in people taking NAD+ precursors like nicotinamide riboside (NR).

Liposomal NAD+ Resveratrol — product photo

Liposomal NAD+ Resveratrol

300 mg NR + 100 mg trans-resveratrol per 4 mL · liposomal berry liquid, no capsules · 30 servings

✓ Doctor formulated✓ Third-party tested✓ GMP certified✓ Non-GMO✓ Made in USA

Get Liquid NAD+ →

$49.99 · free US shipping over $75

Trammell et al. (2016), published in Nature Communications, gave adults single oral doses of nicotinamide riboside at 100, 300, and 1,000 mg and tracked how blood NAD+ metabolites responded over time. The 300 mg dose — the same amount in each 4 mL serving of Liposomal NAD+ Resveratrol — was one of the three doses tested and produced a measurable rise in circulating NAD+ metabolites. It's worth being clear that this was a single-dose study; it says nothing about what happens with repeated daily use.

Airhart et al. (2017), in PLOS ONE, gave 8 healthy adults NR for 9 days, raising the dose to 1,000 mg twice daily, and whole-blood NAD+ roughly doubled. It was a small safety and pharmacokinetics study with no placebo group, and it said nothing about delivery technology like liposomes.

Longer studies exist too, though their outcomes are mixed. Martens et al. (2018), in Nature Communications, ran a randomised trial of 1,000 mg/day NR against placebo for six weeks in 24 middle-aged and older adults. NAD+ metabolites rose, some cardiovascular markers changed modestly, but several other measured outcomes did not differ from placebo. Remie et al. (2020), in the American Journal of Clinical Nutrition, ran a six-week trial of 1,000 mg/day NR in 13 adults with a higher BMI and found that NAD+ metabolites in muscle rose, while most functional measures, including energy metabolism, did not change. Dollerup et al. (2018), in the same journal, looked at 12 weeks of NR in men with a higher body mass index — a population-specific finding that doesn't generalize to women or other groups.

Taken together, this research base establishes that oral NR, in standard (non-liposomal) capsule form, can raise blood NAD+ metabolites in several specific trials. It does not establish a consistent functional benefit across the board, and none of these trials tested a liposomal version of NR at all.

Is There Any Direct Evidence Liposomal Delivery Improves NAD+ Precursor Absorption?

This is the honest, slightly unsatisfying answer: not yet, at least not in a published human trial specific to NAD+ precursors. The liposomal delivery concept has a reasonable biochemical rationale and has been explored for various other nutrients, but no study on this list — or that we're aware of in the published literature — has taken NR or NMN, split it into a liposomal arm and a standard capsule arm, and directly compared blood metabolite levels between the two.

That's an important gap to be upfront about. It means any claim that liposomal NAD+ precursor liquid "absorbs better" than capsules is not something that has been directly tested and confirmed in the way, say, Trammell et al. (2016) tested different oral NR doses against each other. The liposomal rationale is plausible and worth taking seriously, but plausible is not the same as proven.

We go deeper into the liquid-versus-capsule question specifically — including practical tradeoffs around convenience, taste, and dosing precision — in Liposomal NAD+ Liquid vs Capsules: Which Is Better?

Liquid vs. Capsule: Practical Differences That Don't Depend on Absorption

Even without a definitive absorption answer, there are real differences between liquid and capsule formats worth weighing.

Dosing Precision

Capsules deliver a fixed, pre-measured amount every time. Liquids require measuring with a dropper or cap, which introduces more room for inconsistency, especially if a bottle isn't shaken or measured carefully.

Convenience and Travel

Capsules travel well, require no refrigeration consideration, and can be taken anywhere without equipment. Liquids can be messier to transport and may have different storage requirements once opened.

Taste and Daily Experience

Some liquid formulations have a flavor or texture that not everyone finds pleasant to take daily. Capsules sidestep that entirely.

Stability Over Time

How any formulation — liquid or capsule — holds up over its shelf life depends heavily on manufacturing and packaging choices, not simply on whether it's liquid or solid.

Where NutraHack Labs' Liposomal NAD+ Resveratrol Fits

Liposomal NAD+ Resveratrol is a liquid: a 4 fl oz (120 mL) bottle holding 30 servings of 4 mL (just under one teaspoon), in a Fruity Berry flavor. Each 4 mL serving provides Nicotinamide Riboside Hydrogen Malate 300 mg and Resveratrol (as Trans-Resveratrol 98%) 100 mg, carried in a phospholipid complex from sunflower lecithin.

Its NAD+ precursor is nicotinamide riboside (NR), not NMN. The label directions are to take 4 milliliters (just under one teaspoon) daily, or as directed by your healthcare provider; shake before use; it can be mixed with your favorite beverage; refrigeration is not necessary but recommended for taste; and use within 90 days of opening. It is taken by mouth like any drink.

The choice of NR over NMN is worth noting on its own. NR has a longer track record of published human research, including the dosing studies above, while NMN research is newer and, as covered in our NAD+ guide, carries its own open questions about independence of funding and study design in several of the available trials. For readers who prefer a capsule, NutraHack Labs also offers Liposomal NAD+ For Women, a capsule formula that adds collagen, hyaluronic acid and other ingredients.

Pairing NR with trans-resveratrol reflects a formulation choice some supplement makers have made, though it's worth being direct that this specific combination, in this specific product, has not itself been the subject of a published clinical trial. The individual ingredients each have their own separate bodies of research, but the combination as formulated has not been tested together.

Who Might Consider an NAD+ Precursor Supplement

Research has observed that tissue NAD+ levels tend to be lower in older adults compared to younger ones — this was a measurement finding from Massudi et al. (2012) in PLOS ONE, not a test of any intervention. Review articles, including Imai and Guarente (2014) in Trends in Cell Biology and Yoshino, Baur, and Imai (2018) in Cell Metabolism, have connected this kind of decline to broader cellular aging processes studied in other research, but as reviews, they describe associations found elsewhere rather than establishing that any particular supplement changes outcomes in people.

Given that background, adults interested in supporting their body's NAD+ availability as part of a broader wellness routine are the typical audience for this category of product — not people looking for a guaranteed, measurable functional outcome, since the clinical trial evidence on that front remains mixed, as the Martens and Remie trials above illustrate.

Dosage Considerations

The 300 mg NR dose in each serving of Liposomal NAD+ Resveratrol matches one of the three doses tested in Trammell et al. (2016), where it produced a measurable rise in blood NAD+ metabolites following a single dose. It's a lower figure than the 1,000 mg/day used in the six-week Martens et al. (2018) trial, so it shouldn't be assumed to produce identical results to that specific study — different doses, different timeframes, and liposomal versus standard delivery all vary between these research designs and any single product.

Safety data on NR comes from Conze et al. (2019), published in Scientific Reports, which tested nicotinamide riboside chloride at 100, 300 and 1,000 mg/day for 8 weeks in otherwise healthy adults with a higher BMI and reported that adverse events did not differ from placebo. That study measured tolerability, not whether NR produces a benefit.

Food Sources of NAD+ Precursors

NAD+ itself and its precursors appear in trace amounts in foods like milk, yeast, and some vegetables, though dietary intake alone generally supplies far smaller quantities than what's used in the clinical research above. Bogan and Brenner (2008), in the Annual Review of Nutrition, reviewed the overlapping biochemical pathways the body uses to make NAD+ from various dietary precursors, which is useful background on how the body processes these compounds generally, though that review did not test any specific supplement or delivery method. For more on dietary sources specifically, see Can You Get NAD+ From Food? What Research Shows.

Who Should Be Cautious

Anyone pregnant, nursing, taking prescription medication, or managing a diagnosed condition should talk to a healthcare provider before adding an NAD+ precursor supplement, given the relatively young and still-developing state of the long-term human research. People sensitive to any of the formula's ingredients — such as sunflower lecithin, stevia leaf extract or the preservatives potassium sorbate and sodium benzoate — should review the label closely. As with any supplement, more is not automatically better, and taking doses far outside what's been studied isn't advisable.

Studies mentioned

  • Massudi et al., 2012, PLOS ONE, doi:10.1371/journal.pone.0042357 — measured NAD+ levels in human skin tissue across age groups
  • Imai and Guarente, 2014, Trends in Cell Biology, doi:10.1016/j.tcb.2014.04.002 — review of NAD+ and the sirtuin enzymes in aging
  • Trammell et al., 2016, Nature Communications, doi:10.1038/ncomms12948 — single oral doses of 100, 300 and 1,000 mg nicotinamide riboside and blood NAD+ metabolites
  • Airhart et al., 2017, PLOS ONE, doi:10.1371/journal.pone.0186459 — 9-day safety and pharmacokinetics study of escalating nicotinamide riboside doses in 8 healthy adults
  • Martens et al., 2018, Nature Communications, doi:10.1038/s41467-018-03421-7 — six-week randomized crossover trial of nicotinamide riboside in middle-aged and older adults
  • Dollerup et al., 2018, American Journal of Clinical Nutrition, doi:10.1093/ajcn/nqy132 — 12-week trial of nicotinamide riboside in men with a higher body mass index
  • Yoshino, Baur, and Imai, 2018, Cell Metabolism, doi:10.1016/j.cmet.2017.11.002 — review of the NAD+ intermediates NR and NMN
  • Conze et al., 2019, Scientific Reports, doi:10.1038/s41598-019-46120-z — 8-week safety study of nicotinamide riboside chloride at three doses
  • Remie et al., 2020, American Journal of Clinical Nutrition, doi:10.1093/ajcn/nqaa072 — six-week trial of nicotinamide riboside in 13 adults with a higher BMI, measuring muscle NAD+ metabolites and metabolic markers

Frequently Asked Questions

Does liposomal NAD+ liquid absorb better than capsules?

No published human trial has directly compared liposomal liquid against standard capsules specifically for NAD+ precursor absorption. The liposomal delivery technique has a reasonable rationale studied in other nutrient contexts, but this exact comparison hasn't been run and confirmed for NR or NMN.

Is liposomal the same thing as liquid?

No. Liposomal describes a delivery technique — wrapping a compound in a phospholipid shell — that can be put into a liquid, a soft-gel capsule, or other formats. Liquid versus capsule is a separate, format-level choice.

What's the difference between NR and NMN?

Both are NAD+ precursors studied in separate lines of human research. NR has a longer track record of published trials, including dosing and six-week studies. NMN research is newer and includes some studies with notable funding or design limitations. Our NAD+ vs NADH guide covers related distinctions in more depth.

How much NR does Liposomal NAD+ Resveratrol contain?

Each 4 mL serving contains 300 mg Nicotinamide Riboside Hydrogen Malate and 100 mg trans-resveratrol (98%), in a liposomal liquid; the 4 fl oz (120 mL) bottle holds 30 servings.

How long does it take to notice anything from an NAD+ precursor supplement?

Blood NAD+ metabolite changes have been observed within hours in single-dose studies, but functional outcomes in longer trials have been mixed. See How Long Does NAD+ Take to Work? for a detailed timeline breakdown.

Can I get enough NAD+ precursors from food alone?

Food sources generally provide much smaller amounts of NAD+ precursors than the doses used in clinical research. See Can You Get NAD+ From Food? What Research Shows for more detail.

If you're trying to decide between formats, the most honest starting point is matching the ingredient and dose to what's actually been studied — not the format alone. You can review the full ingredient panel and directions for Liposomal NAD+ Resveratrol and decide whether a liquid fits your routine; no trial has tested it head-to-head against a capsule.

Liposomal NAD+ Resveratrol — product photo

Liposomal NAD+ Resveratrol

300 mg NR + 100 mg trans-resveratrol per 4 mL · liposomal berry liquid, no capsules · 30 servings

✓ Doctor formulated✓ Third-party tested✓ GMP certified✓ Non-GMO✓ Made in USA

Get Liquid NAD+ →

$49.99 · free US shipping over $75

* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.